Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Feb 8, 2011


BioNanomatrix's board has appointed Erik Holmlin as CEO, president, and director, succeeding Edward Erickson, who is now CEO at Saladax Biomedical.

Prior to joining BioNanomatrix, Holmlin served as CEO and president of GenVault, which merged with IntegenX last month. Prior to that he was chief commercial officer at Exiqon, where he was responsible for global sales, marketing, and clinical affairs for oncology services in a CLIA lab and a consumables business. In 2001, he founded molecular diagnostics company GeneOhm Sciences, which was acquired by Becton Dickinson in 2006.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.